Search
Mural Oncology PLC
MURAAdd to Watchlist
2.040USD
0.0000.00%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
35.38MMarket Cap
LossP/E TTM
Earnings Forecast
Currency: USD Updated:Analyst Rating
Based on
1
analysts
Hold
Current Rating
6.000
Target Price
+191.26%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
562
Total
5
Median
6
Average
Company name
Ratings
Analysts
Mural Oncology PLC
MURA
1
Ionis Pharmaceuticals Inc
IONS
27
Beigene Ltd
ONC
27
CRISPR Therapeutics AG
CRSP
27
IQVIA Holdings Inc
IQV
26
argenx SE
ARGX
26
1
2
3
...
113
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
How have Mural Oncology PLCMURA's recent earnings per share performed?
The market expectation was USD -0.21, while Mural Oncology PLCMURA's earnings per share (EPS) for the previous quarter was USD -2.78. EPS for the next quarter is expected at USD -0.37.
What is the analyst rating for Mural Oncology PLC?
Based on the ratings of Mural Oncology PLC's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.